Mechanisms of androgen receptor repression in prostate cancer

Biochemical Society Transactions

Volumn 34, Issue 6, 2006, Pages 1124-1127

  Powell, S M ^a   Brooke, G N ^a   Whitaker, H C ^a,c   Reebye, V ^a   Gamble, S C ^a   Chotai, D ^a   Dart, D A ^a   Belandia, B ^b   Bevan, C L ^a  

^a HAMMERSMITH HOSPITAL   (United Kingdom)

^b INSTITUTO DE INVESTIGACIONES BIOMÉDICAS ALBERTO SOLS   (Spain)

^c UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

Androgen receptor; Anti androgen; Bicalutamide; Co repressor; Hey1; Prostate cancer therapy

Indexed keywords

ANDROGEN RECEPTOR; ANTIANDROGEN; BICALUTAMIDE; HYDROXYFLUTAMIDE; NOTCH RECEPTOR; PROTEIN HEY1; STEROID RECEPTOR; UNCLASSIFIED DRUG; ANTINEOPLASTIC AGENT;

ARTICLE; CELL NUCLEUS; CELLULAR DISTRIBUTION; DNA BINDING; DRUG BINDING; DRUG INHIBITION; GENE REPRESSION; GENE TRANSLOCATION; HUMAN; IN VIVO STUDY; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN INTERACTION; BIOLOGICAL MODEL; MALE; PATHOLOGY; PATHOPHYSIOLOGY; PROSTATE HYPERTROPHY; PROSTATE TUMOR;

ANDROGEN ANTAGONISTS; ANTINEOPLASTIC AGENTS; HUMANS; MALE; MODELS, BIOLOGICAL; PROSTATIC HYPERPLASIA; PROSTATIC NEOPLASMS;

EID: 34248673174     PISSN: 03005127     EISSN: None     Source Type: Journal    
DOI: 10.1042/BST0341124     Document Type: Article

References (17)

1. Labrie, F. (1991) Endocrinol. Metab. Clin. North. Am. 20, 845-872
2. Feldman, B.J. and Feldman, D. (2001) Nat. Rev. Cancer 1, 34-45
3. Mangelsdorf, D.J., Thummel, C., Beato, M., Herrlich, P., Schutz, G., Umesono, K., Blumberg, B., Kastner, P., Mark, M., Chambon, P. and Evans, R.M. (1995) Cell 83, 835-839
4. Knoblauch, R. and Garabedian, M.J. (1999) Mol. Cell. Biol. 19, 3748-3759
5. McKenna, N.J., Lanz, R.B. and O'Malley, B.W. (1999) Endocr. Rev. 20, 321-344
6. Dauvois, S., White, R. and Parker, M.G. (1993) J. Cell Sci. 106, 1377-1388
7. Farla, P., Hersmus, R., Trapman, J. and Houtsmuller, A.B. (2005) J. Cell Sci. 118, 4187-4198
8. Masiello, D., Cheng, S., Bubley, G.J., Lu, M.L. and Balk, S.P. (2002) J. Biol. Chem. 277, 26321-26326
9. Whitaker, H.C., Hanrahan, S., Totty, N., Gamble, S.C., Waxman, J., Cato, A.C., Hurst, H.C. and Bevan, C.L. (2006) Clin. Cancer Res. 10, 7392-7401
10. Jackson, T.A., Richer, J.K., Bain, D.L., Takimoto, G.S., Tung, L. and Horwitz, K.B. (1997) Mol. Endocrinol. 11, 693-705
11. Hodgson, M.C., Astapova, I., Cheng, S., Lee, L.J., Verhoeven, M.C., Choi, E., Balk, S.P. and Hollenberg, A.N. (2005) J. Biol. Chem. 280, 6511-6519
12. Belandia, B., Powell, S.M., Garcia-Pedrero, J.M., Walker, M.M., Bevan, C.L. and Parker, M.G. (2005) Mol. Cell. Biol. 25, 1425-1436
13. Fujimoto, N., Mizokami, A., Harada, S. and Matsumoto, T. (2001) Urology 58, 289-294
14. Linja, M.J., Porkka, K.P., Kang, Z., Savinainen, K.J., Janne, O.A., Tammela, T.L., Vessella, R.L., Palvimo, J.J. and Visakorpi, T. (2004) Clin. Cancer Res. 10, 1032-1040
15. Culig, Z., Comuzzi, B., Steiner, H., Bartsch, G. and Hobisch, A. (2004) J. Steroid Biochem. Mol. Biol. 92, 265-271
16. Baek, S.H., Ohgi, K.A., Rose, D.W., Koo, E.H., Glass, C.K. and Rosenfeld, M.G. (2002) Cell 110, 55-67
17. Morris, C. and Wakeling, A. (2002) Endocr. Relat. Cancer 9, 267-276